Skyepharma’s proprietary drug delivery technologies have been incorporated into many approved products that are sold by pharmaceutical companies in over 80 countries, where they provide important clinical benefits for patients and offer additional proprietary protection.
We have partnered with a wide range of companies, from big pharma such as GlaxoSmithKline, Novartis, Sanofi, Janssen and Roche, to medium-sized companies like Mundipharma and Kyorin, and smaller specialty pharmaceutical companies. We use our know-how and capabilities, and where appropriate apply Our proprietary drug delivery technologies and expertise to the development of pharmaceutical products in order to improve patient outcomes and provide additional proprietary protection for our partners.
Find out more about inhalation and oral products that incorporate our drug delivery technologies and that we have helped to develop. We are also developing some novel products of our own.
Contact us if you would like to discuss potential collaboration with Skyepharma.